canSAR: update to the cancer translational research and drug discovery knowledgebase.
Nucleic Acids Res
; 47(D1): D917-D922, 2019 01 08.
Article
em En
| MEDLINE
| ID: mdl-30496479
ABSTRACT
canSAR (http//cansar.icr.ac.uk) is a public, freely available, integrative translational research and drug discovery knowlegebase. canSAR informs researchers to help solve key bottlenecks in cancer translation and drug discovery. It integrates genomic, protein, pharmacological, drug and chemical data with structural biology, protein networks and unique, comprehensive and orthogonal 'druggability' assessments. canSAR is widely used internationally by academia and industry. Here we describe major enhancements to canSAR including new and expanded data. We also describe the first components of canSARblack-an advanced, responsive, multi-device compatible redesign of canSAR with a question-led interface.
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Bases de Conhecimento
/
Descoberta de Drogas
/
Bases de Dados de Produtos Farmacêuticos
/
Antineoplásicos
Idioma:
En
Ano de publicação:
2019
Tipo de documento:
Article